SCHEMBL6004192

SCHEMBL6004192

O=C(Nc1ccccc1Cl)c1ccn(C(=O)OCc2ccccc2Cl)n1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.58
RAB9A P51151 4/20 0.55
NPC1 O15118 3/20 0.55
F2 P00734 1/20 0.53
ALOX15 P16050 1/20 0.53
SMN1; SMN2 Q16637 2/20 0.46
HTT P42858 1/20 0.46
EPHB3 P54753 5/20 0.44
FAAH O00519 1/20 0.43
MGLL Q99685 1/20 0.43
MEN1 O00255 2/20 0.43
RIPK2 O43353 1/20 0.43
LCK P06239 1/20 0.43
MAPT P10636 1/20 0.43
LMNA P02545 1/20 0.43
PKM P14618 1/20 0.42
CASP3 P42574 1/20 0.42
SENP8 Q96LD8 1/20 0.42
SENP7 Q9BQF6 1/20 0.42
SENP6 Q9GZR1 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6003833 0.92 KMT2A (0.61) KMT2ARAB9ANPC1F2ALOX15
SCHEMBL6002576 0.86 RAB9A (0.49) KMT2ARAB9ANPC1F2ALOX15
SCHEMBL6004828 0.79 RAB9A (0.63) KMT2ARAB9ANPC1F2SMN1; SMN2
SCHEMBL6004813 0.78 RAB9A (0.53) KMT2ARAB9ANPC1F2ALOX15
SCHEMBL6002581 0.76 MGLL (0.41) KMT2ARAB9ANPC1F2ALOX15
SCHEMBL6003824 0.76 MGLL (0.43) KMT2ARAB9ANPC1F2ALOX15
SCHEMBL8300306 0.74 KMT2A (1.00) KMT2ARAB9ANPC1F2ALOX15
SCHEMBL13210095 0.72 RAB9A (0.60) KMT2ARAB9ANPC1F2ALOX15
SCHEMBL6469936 0.72 CASP3 (0.52) KMT2ARAB9ANPC1F2HTT
SCHEMBL21883158 0.69 KMT2A (0.52) KMT2ARAB9ANPC1F2ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060183780-A1 Pyrazole compounds useful in the treatment of inflammation BIOLIPOX AB (SE) 2006-08-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060183780-A1 Pyrazole compounds useful in the treatment of inflammation ALOX15, ALOX12, ALOX15B KMT2A 4358/4885RAB9A 3284/4885NPC1 3112/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.